Sep 4, 2019

Trump administration voids requirements phasing out inefficient lightbulbs

Compact fluorescent lightbulbs. Photo: Justin Sullivan/Getty Images

The Department of Energy on Wednesday unveiled new rules that annul Bush-era requirements on energy-saving lightbulbs slated to go into effect on Jan. 1, 2020, according to the New York Times.

Why it matters: The new rules could make less-efficient bulbs for certain fixtures more common, potentially contributing to man-made climate change by increasing greenhouse gas emissions. Politically, it's part of the Trump administration's broader efforts to roll back climate and other environmental regulations, such as those governing methane and auto emissions. A bipartisan Congress approved the policy to phase out less-efficient bulbs under Republican President George W. Bush in 2007.

Where it stands, via the Times: "One part of the new standards would have required the adding of four kinds of incandescent and halogen light bulbs to the energy-efficient group: three-way, the candle-shaped bulbs used in chandeliers; the globe-shaped bulbs found in bathroom lighting; reflector bulbs used in recessed fixtures; and track lighting. A rule that will be published Thursday in the Federal Register will eliminate the requirement for those four categories of bulbs."

What's next: Expect energy conservation groups to challenge the changes in court.

  • Noah Horowitz, director of the Center for Energy Efficiency Standards at the Natural Resources Defense Council, told the Times last week: "We will explore all options, including litigation, to stop this completely misguided and unlawful action."

Go deeper

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 2 p.m. ET: 5,453,784 — Total deaths: 345,886 — Total recoveries — 2,191,310Map.
  2. U.S.: Total confirmed cases as of 2 p.m. ET: 1,651,254 — Total deaths: 97,850 — Total recoveries: 366,736 — Total tested: 14,163,915Map.
  3. World: Top Boris Johnson aide defends himself after allegations he broke U.K. lockdown — WHO suspends trial of hydroxychloroquine over safety concerns.
  4. 2020: Trump threatens to move Republican convention from North Carolina — Joe Biden makes first public appearance in two months.
  5. Public health: Officials are urging Americans to wear masks over Memorial Day.
  6. Economy: White House economic adviser Kevin Hassett says it's possible the unemployment rate could still be in double digits by November's election — Charities refocus their efforts to fill gaps left by government.
  7. What should I do? Hydroxychloroquine questions answeredTraveling, asthma, dishes, disinfectants and being contagiousMasks, lending books and self-isolatingExercise, laundry, what counts as soap — Pets, moving and personal healthAnswers about the virus from Axios expertsWhat to know about social distancingHow to minimize your risk.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it, the right mask to wear.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Updated 15 mins ago - Politics & Policy

Joe Biden makes first public appearance in over two months

Photo: Oliver Douliery/AFP via Getty Images

Former Vice President Joe Biden made his first in-person appearance in over two months on Monday to honor Memorial Day by laying a wreath at a Delaware veterans park, AP reports.

Why it matters: Biden, the Democratic Party's presumptive nominee, has taken the unprecedented step of campaigning from his home during the coronavirus pandemic, ever since canceling a rally in Cleveland on March 10.

WHO temporarily suspends trial of hydroxychloroquine over safety concerns

Photo: Fabrice Coffrini/AFP via Getty Images

The World Health Organization is temporarily pausing tests of the anti-malarial drug hydroxychloroquine as a coronavirus treatment in order to review safety concerns, the agency's director-general Tedros Adhanom Ghebreyesu said Monday.

Why it matters: The decision comes after a retrospective review published in The Lancet found that coronavirus patients who took hydroxychloroquine or its related drug chloroquine were more likely to die or develop an irregular heart rhythm that can lead to sudden cardiac death, compared to those who did nothing.